Consideration of Tranexamic Acid Administration to COVID-19 Patients.

Ogawa, Haruhiko; Asakura, Hidesaku

Ogawa, Haruhiko; Asakura, Hidesaku.

Ogawa H; Department of Environmental and Preventive Medicine, Kanazawa University, Kanazawa, Ishikawa, Japan; and Department of Hematology, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan.
Asakura H; Department of Environmental and Preventive Medicine, Kanazawa University, Kanazawa, Ishikawa, Japan; and Department of Hematology, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan.

Physiol Rev ; 100(4): 1595-1596, 2020 10 01.

Article in English | MEDLINE | ID: covidwho-636317

Subject(s)

Coronavirus Infections; Fibrinolysin; Pandemics; Pneumonia, Viral; Tranexamic Acid; Betacoronavirus; COVID-19; Estrone/analogs & derivatives; Humans; Risk Factors; SARS-CoV-2

Keywords

COVID-19; plasmin; thrombosis; tranexamic acid

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Tranexamic Acid / Fibrinolysin / Coronavirus Infections / Pandemics Type of study: Prognostic study Limits: Humans Language: English Journal: Physiol Rev Year: 2020 Document Type: Article Affiliation country: Physrev.00023.2020

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google